Amgen

US · AMGN #59 by market cap Listed 1970 Quant Rating C 67

437.23 -6.89 -1.55%

Collector offline (last heartbeat: 19063s ago) · 2026-09-04 19:59

Pre-market 438.95 -1.16%

After-hours 415.00 -5.08%

Overnight 442.22 -0.43%

Market cap: 236.38B
P/E (TTM): 27.16
P/B: 20.22
EPS: 14.23
Div yield: 2.24%
52W pos: 95%

About Amgen

Amgen is a biotechnology company that discovers, develops and markets therapeutics across a broad range of disease areas. William Bowes Jr., Franklin Johnson Jr., George Rathmann and Joseph Rubinfeld founded the company on April 8, 1980; it is headquartered in Thousand Oaks, California.

Founded: 1980
CEO: Mr. Robert A. Bradway
Employees: 31,500
Headquarters: Thousand Oaks, California, United States of America
Fiscal year end: 12-31
Website: amgen.com

View SEC filings on EDGAR ›

Company profile

Exchange: US
Symbol: AMGN
Market-cap rank: #59
Listing date: 1970-01-01
Market cap: 236.38B
Float cap: 235.74B
Shares out: 540.63M
Float shares: 539.16M

Sectors & themes

Drug Manufacturers - General CAR-T Therapy Weight Loss Drugs ARK Portfolio Government Pension Fund of Norway Global medical industry Regular Savings Plan Fractional Shares JP Star Stocks

Browse all sectors & themes

Quote time 2026-09-04 19:59:10

For reference only, not investment advice.